Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1992 Dec 15;288(Pt 3):1053–1059. doi: 10.1042/bj2881053

A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion.

J Ghiso 1, A Rostagno 1, J E Gardella 1, L Liem 1, P D Gorevic 1, B Frangione 1
PMCID: PMC1131993  PMID: 1281980

Abstract

Amyloid beta (A beta), the major constituent of the fibrils composing senile plaques and vascular amyloid deposits in Alzheimer's disease (AD) and related disorders, is a 39-42-residue self-aggregating degradation peptide of a larger multidomain membrane glycoprotein designated amyloid precursor protein (APP). An array of biological functions has been assigned to different APP domains, including growth regulation, neurotoxicity, inhibitory activity of serine proteinases and promotion of cell-cell and cell-matrix interactions. A beta is generated through an as-yet-unknown catabolic pathway that by-passes or inhibits the cleavage of APP within the A beta sequence. We have identified a 16 kDa intermediate APP C-terminal fragment containing A beta in leptomeningeal vessels of aged normal individuals and AD patients by means of its immunoreactivity with a panel of four different anti-(APP C-terminal) antibodies, indicating a different pathway of APP processing. Previous studies have indicated that the APP C-terminal domain is the most likely to be involved in cell-matrix interactions. A 109-amino-acid construct C109 with a sequence analogous to the C-terminal of APP (positions 587-695 of APP695), similar in length and immunoreactivity to the 16 kDa fragment, was found to promote cell adhesion. By use of synthetic peptides, this activity was initially located to the extracellular 28 residues of A beta. Inhibition studies demonstrated that the sequence RHDS (amino acids 5-8 of A beta, corresponding to residues 601-604 of APP695 was responsible for the adhesion-promoting activity. The interaction is dependent on bivalent cations and can be blocked either by the tetrapeptides RHDS and RGDS or by an anti-(beta 1 integrin) antibody. Thus, through integrin-like surface receptors, APP or its derivative proteolytic fragments containing the sequence RHDS may modulate cell-cell or cell-matrix interactions.

Full text

PDF
1053

Images in this article

1056Fig. 1.
on p.1056
1056Fig. 2.
on p.1056

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. P., Esch F. S., Keim P. S., Sambamurti K., Lieberburg I., Robakis N. K. Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells. Neurosci Lett. 1991 Jul 8;128(1):126–128. doi: 10.1016/0304-3940(91)90775-o. [DOI] [PubMed] [Google Scholar]
  2. Bodmer S., Podlisny M. B., Selkoe D. J., Heid I., Fontana A. Transforming growth factor-beta bound to soluble derivatives of the beta amyloid precursor protein of Alzheimer's disease. Biochem Biophys Res Commun. 1990 Sep 14;171(2):890–897. doi: 10.1016/0006-291x(90)91229-l. [DOI] [PubMed] [Google Scholar]
  3. Breen K. C., Bruce M., Anderton B. H. Beta amyloid precursor protein mediates neuronal cell-cell and cell-surface adhesion. J Neurosci Res. 1991 Jan;28(1):90–100. doi: 10.1002/jnr.490280109. [DOI] [PubMed] [Google Scholar]
  4. Bush A. I., Martins R. N., Rumble B., Moir R., Fuller S., Milward E., Currie J., Ames D., Weidemann A., Fischer P. The amyloid precursor protein of Alzheimer's disease is released by human platelets. J Biol Chem. 1990 Sep 15;265(26):15977–15983. [PubMed] [Google Scholar]
  5. Buxbaum J. D., Gandy S. E., Cicchetti P., Ehrlich M. E., Czernik A. J., Fracasso R. P., Ramabhadran T. V., Unterbeck A. J., Greengard P. Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. Proc Natl Acad Sci U S A. 1990 Aug;87(15):6003–6006. doi: 10.1073/pnas.87.15.6003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Castaño E. M., Ghiso J., Prelli F., Gorevic P. D., Migheli A., Frangione B. In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein. Biochem Biophys Res Commun. 1986 Dec 15;141(2):782–789. doi: 10.1016/s0006-291x(86)80241-8. [DOI] [PubMed] [Google Scholar]
  7. Castaño E. M., Wisniewski T., Frangione B. Inherited amyloids of the nervous system. Curr Opin Neurobiol. 1991 Oct;1(3):448–454. doi: 10.1016/0959-4388(91)90068-i. [DOI] [PubMed] [Google Scholar]
  8. Chen M., Yankner B. A. An antibody to beta amyloid and the amyloid precursor protein inhibits cell-substratum adhesion in many mammalian cell types. Neurosci Lett. 1991 Apr 29;125(2):223–226. doi: 10.1016/0304-3940(91)90034-q. [DOI] [PubMed] [Google Scholar]
  9. Cole G. M., Galasko D., Shapiro I. P., Saitoh T. Stimulated platelets release amyloid beta-protein precursor. Biochem Biophys Res Commun. 1990 Jul 16;170(1):288–295. doi: 10.1016/0006-291x(90)91272-t. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dyrks T., Weidemann A., Multhaup G., Salbaum J. M., Lemaire H. G., Kang J., Müller-Hill B., Masters C. L., Beyreuther K. Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease. EMBO J. 1988 Apr;7(4):949–957. doi: 10.1002/j.1460-2075.1988.tb02900.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Engvall E., Ruoslahti E. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer. 1977 Jul 15;20(1):1–5. doi: 10.1002/ijc.2910200102. [DOI] [PubMed] [Google Scholar]
  12. Esch F. S., Keim P. S., Beattie E. C., Blacher R. W., Culwell A. R., Oltersdorf T., McClure D., Ward P. J. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science. 1990 Jun 1;248(4959):1122–1124. doi: 10.1126/science.2111583. [DOI] [PubMed] [Google Scholar]
  13. Estus S., Golde T. E., Kunishita T., Blades D., Lowery D., Eisen M., Usiak M., Qu X. M., Tabira T., Greenberg B. D. Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science. 1992 Feb 7;255(5045):726–728. doi: 10.1126/science.1738846. [DOI] [PubMed] [Google Scholar]
  14. Ferreira O. C., Jr, Garcia-Pardo A., Bianco C. Specific binding of the human monocytic cell line U937 to the alternatively spliced connecting segment (IIICS) of fibronectin. J Exp Med. 1990 Jan 1;171(1):351–356. doi: 10.1084/jem.171.1.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gandy S. E., Bhasin R., Ramabhadran T. V., Koo E. H., Price D. L., Goldgaber D., Greengard P. Alzheimer beta/A4-amyloid precursor protein: evidence for putative amyloidogenic fragment. J Neurochem. 1992 Jan;58(1):383–386. doi: 10.1111/j.1471-4159.1992.tb09322.x. [DOI] [PubMed] [Google Scholar]
  16. Gandy S., Czernik A. J., Greengard P. Phosphorylation of Alzheimer disease amyloid precursor peptide by protein kinase C and Ca2+/calmodulin-dependent protein kinase II. Proc Natl Acad Sci U S A. 1988 Aug;85(16):6218–6221. doi: 10.1073/pnas.85.16.6218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Garcia-Pardo A., Ferreira O. C., Valinsky J., Bianco C. Fibronectin receptors of mononuclear phagocytes: binding characteristics and biochemical isolation. Exp Cell Res. 1989 Apr;181(2):420–431. doi: 10.1016/0014-4827(89)90099-2. [DOI] [PubMed] [Google Scholar]
  18. Gardella J. E., Ghiso J., Gorgone G. A., Marratta D., Kaplan A. P., Frangione B., Gorevic P. D. Intact Alzheimer amyloid precursor protein (APP) is present in platelet membranes and is encoded by platelet mRNA. Biochem Biophys Res Commun. 1990 Dec 31;173(3):1292–1298. doi: 10.1016/s0006-291x(05)80927-1. [DOI] [PubMed] [Google Scholar]
  19. Gardella J. E., Gorgone G. A., Munoz P. C., Ghiso J., Frangione B., Gorevic P. D. Beta protein precursor expression in human platelets and a megakaryocyte cell line. Possible implications for the origin of cerebral amyloidosis in Alzheimer's disease. Lab Invest. 1992 Sep;67(3):303–313. [PubMed] [Google Scholar]
  20. Ghiso J., Haltia M., Prelli F., Novello J., Frangione B. Gelsolin variant (Asn-187) in familial amyloidosis, Finnish type. Biochem J. 1990 Dec 15;272(3):827–830. doi: 10.1042/bj2720827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Ghiso J., Tagliavini F., Timmers W. F., Frangione B. Alzheimer's disease amyloid precursor protein is present in senile plaques and cerebrospinal fluid: immunohistochemical and biochemical characterization. Biochem Biophys Res Commun. 1989 Aug 30;163(1):430–437. doi: 10.1016/0006-291x(89)92154-2. [DOI] [PubMed] [Google Scholar]
  22. Ghiso J., Wisniewski T., Vidal R., Rostagno A., Frangione B. Epitope map of two polyclonal antibodies that recognize amyloid lesions in patients with Alzheimer's disease. Biochem J. 1992 Mar 1;282(Pt 2):517–522. doi: 10.1042/bj2820517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gillies R. J., Didier N., Denton M. Determination of cell number in monolayer cultures. Anal Biochem. 1986 Nov 15;159(1):109–113. doi: 10.1016/0003-2697(86)90314-3. [DOI] [PubMed] [Google Scholar]
  24. Glenner G. G., Wong C. W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984 May 16;120(3):885–890. doi: 10.1016/s0006-291x(84)80190-4. [DOI] [PubMed] [Google Scholar]
  25. Golde T. E., Estus S., Younkin L. H., Selkoe D. J., Younkin S. G. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science. 1992 Feb 7;255(5045):728–730. doi: 10.1126/science.1738847. [DOI] [PubMed] [Google Scholar]
  26. Gorevic P. D., Castano E. M., Sarma R., Frangione B. Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic x-ray diffraction pattern. Biochem Biophys Res Commun. 1987 Sep 15;147(2):854–862. doi: 10.1016/0006-291x(87)91008-4. [DOI] [PubMed] [Google Scholar]
  27. Haass C., Schlossmacher M. G., Hung A. Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B. L., Lieberburg I., Koo E. H., Schenk D., Teplow D. B. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature. 1992 Sep 24;359(6393):322–325. doi: 10.1038/359322a0. [DOI] [PubMed] [Google Scholar]
  28. Humphries M. J. The molecular basis and specificity of integrin-ligand interactions. J Cell Sci. 1990 Dec;97(Pt 4):585–592. doi: 10.1242/jcs.97.4.585. [DOI] [PubMed] [Google Scholar]
  29. Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., Multhaup G., Beyreuther K., Müller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987 Feb 19;325(6106):733–736. doi: 10.1038/325733a0. [DOI] [PubMed] [Google Scholar]
  30. Kirschner D. A., Abraham C., Selkoe D. J. X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation. Proc Natl Acad Sci U S A. 1986 Jan;83(2):503–507. doi: 10.1073/pnas.83.2.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Klier F. G., Cole G., Stallcup W., Schubert D. Amyloid beta-protein precursor is associated with extracellular matrix. Brain Res. 1990 May 7;515(1-2):336–342. doi: 10.1016/0006-8993(90)90619-m. [DOI] [PubMed] [Google Scholar]
  32. Lemaire H. G., Salbaum J. M., Multhaup G., Kang J., Bayney R. M., Unterbeck A., Beyreuther K., Müller-Hill B. The PreA4(695) precursor protein of Alzheimer's disease A4 amyloid is encoded by 16 exons. Nucleic Acids Res. 1989 Jan 25;17(2):517–522. doi: 10.1093/nar/17.2.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4245–4249. doi: 10.1073/pnas.82.12.4245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Matsumoto A., Fujiwara Y. Abnormal and deficient processing of beta-amyloid precursor protein in familial Alzheimer's disease lymphoblastoid cells. Biochem Biophys Res Commun. 1991 Mar 15;175(2):361–365. doi: 10.1016/0006-291x(91)91572-t. [DOI] [PubMed] [Google Scholar]
  35. Nordstedt C., Gandy S. E., Alafuzoff I., Caporaso G. L., Iverfeldt K., Grebb J. A., Winblad B., Greengard P. Alzheimer beta/A4 amyloid precursor protein in human brain: aging-associated increases in holoprotein and in a proteolytic fragment. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8910–8914. doi: 10.1073/pnas.88.20.8910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Octave J. N., de Sauvage F., Maloteaux J. M. Modification of neuronal cell adhesion affects the genetic expression of the A4 amyloid peptide precursor. Brain Res. 1989 May 8;486(2):369–371. doi: 10.1016/0006-8993(89)90525-8. [DOI] [PubMed] [Google Scholar]
  37. Oltersdorf T., Fritz L. C., Schenk D. B., Lieberburg I., Johnson-Wood K. L., Beattie E. C., Ward P. J., Blacher R. W., Dovey H. F., Sinha S. The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II. Nature. 1989 Sep 14;341(6238):144–147. doi: 10.1038/341144a0. [DOI] [PubMed] [Google Scholar]
  38. Oltersdorf T., Ward P. J., Henriksson T., Beattie E. C., Neve R., Lieberburg I., Fritz L. C. The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway. J Biol Chem. 1990 Mar 15;265(8):4492–4497. [PubMed] [Google Scholar]
  39. Prelli F., Castaño E., Glenner G. G., Frangione B. Differences between vascular and plaque core amyloid in Alzheimer's disease. J Neurochem. 1988 Aug;51(2):648–651. doi: 10.1111/j.1471-4159.1988.tb01087.x. [DOI] [PubMed] [Google Scholar]
  40. Ruoslahti E., Pierschbacher M. D. New perspectives in cell adhesion: RGD and integrins. Science. 1987 Oct 23;238(4826):491–497. doi: 10.1126/science.2821619. [DOI] [PubMed] [Google Scholar]
  41. Saitoh T., Sundsmo M., Roch J. M., Kimura N., Cole G., Schubert D., Oltersdorf T., Schenk D. B. Secreted form of amyloid beta protein precursor is involved in the growth regulation of fibroblasts. Cell. 1989 Aug 25;58(4):615–622. doi: 10.1016/0092-8674(89)90096-2. [DOI] [PubMed] [Google Scholar]
  42. Schubert D., Cole G., Saitoh T., Oltersdorf T. Amyloid beta protein precursor is a mitogen. Biochem Biophys Res Commun. 1989 Jul 14;162(1):83–88. doi: 10.1016/0006-291x(89)91965-7. [DOI] [PubMed] [Google Scholar]
  43. Schubert D., Jin L. W., Saitoh T., Cole G. The regulation of amyloid beta protein precursor secretion and its modulatory role in cell adhesion. Neuron. 1989 Dec;3(6):689–694. doi: 10.1016/0896-6273(89)90237-7. [DOI] [PubMed] [Google Scholar]
  44. Selkoe D. J. The molecular pathology of Alzheimer's disease. Neuron. 1991 Apr;6(4):487–498. doi: 10.1016/0896-6273(91)90052-2. [DOI] [PubMed] [Google Scholar]
  45. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature. 1992 Sep 24;359(6393):325–327. doi: 10.1038/359325a0. [DOI] [PubMed] [Google Scholar]
  46. Shioi J., Anderson J. P., Ripellino J. A., Robakis N. K. Chondroitin sulfate proteoglycan form of the Alzheimer's beta-amyloid precursor. J Biol Chem. 1992 Jul 15;267(20):13819–13822. [PubMed] [Google Scholar]
  47. Shivers B. D., Hilbich C., Multhaup G., Salbaum M., Beyreuther K., Seeburg P. H. Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. EMBO J. 1988 May;7(5):1365–1370. doi: 10.1002/j.1460-2075.1988.tb02952.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Shoji M., Golde T. E., Ghiso J., Cheung T. T., Estus S., Shaffer L. M., Cai X. D., McKay D. M., Tintner R., Frangione B. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science. 1992 Oct 2;258(5079):126–129. doi: 10.1126/science.1439760. [DOI] [PubMed] [Google Scholar]
  49. Sisodia S. S., Koo E. H., Beyreuther K., Unterbeck A., Price D. L. Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. Science. 1990 Apr 27;248(4954):492–495. doi: 10.1126/science.1691865. [DOI] [PubMed] [Google Scholar]
  50. Smith C. D., Carney J. M., Starke-Reed P. E., Oliver C. N., Stadtman E. R., Floyd R. A., Markesbery W. R. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10540–10543. doi: 10.1073/pnas.88.23.10540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Smith R. P., Higuchi D. A., Broze G. J., Jr Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein. Science. 1990 Jun 1;248(4959):1126–1128. doi: 10.1126/science.2111585. [DOI] [PubMed] [Google Scholar]
  52. Tamaoka A., Kalaria R. N., Lieberburg I., Selkoe D. J. Identification of a stable fragment of the Alzheimer amyloid precursor containing the beta-protein in brain microvessels. Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1345–1349. doi: 10.1073/pnas.89.4.1345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Uéda K., Cole G., Sundsmo M., Katzman R., Saitoh T. Decreased adhesiveness of Alzheimer's disease fibroblasts: is amyloid beta-protein precursor involved? Ann Neurol. 1989 Mar;25(3):246–251. doi: 10.1002/ana.410250307. [DOI] [PubMed] [Google Scholar]
  54. Van Nostrand W. E., Schmaier A. H., Farrow J. S., Cunningham D. D. Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein. Science. 1990 May 11;248(4956):745–748. doi: 10.1126/science.2110384. [DOI] [PubMed] [Google Scholar]
  55. Van Nostrand W. E., Wagner S. L., Suzuki M., Choi B. H., Farrow J. S., Geddes J. W., Cotman C. W., Cunningham D. D. Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor. Nature. 1989 Oct 12;341(6242):546–549. doi: 10.1038/341546a0. [DOI] [PubMed] [Google Scholar]
  56. Wang R., Meschia J. F., Cotter R. J., Sisodia S. S. Secretion of the beta/A4 amyloid precursor protein. Identification of a cleavage site in cultured mammalian cells. J Biol Chem. 1991 Sep 5;266(25):16960–16964. [PubMed] [Google Scholar]
  57. Weidemann A., König G., Bunke D., Fischer P., Salbaum J. M., Masters C. L., Beyreuther K. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell. 1989 Apr 7;57(1):115–126. doi: 10.1016/0092-8674(89)90177-3. [DOI] [PubMed] [Google Scholar]
  58. Whitson J. S., Glabe C. G., Shintani E., Abcar A., Cotman C. W. Beta-amyloid protein promotes neuritic branching in hippocampal cultures. Neurosci Lett. 1990 Mar 14;110(3):319–324. doi: 10.1016/0304-3940(90)90867-9. [DOI] [PubMed] [Google Scholar]
  59. Whitson J. S., Selkoe D. J., Cotman C. W. Amyloid beta protein enhances the survival of hippocampal neurons in vitro. Science. 1989 Mar 17;243(4897):1488–1490. doi: 10.1126/science.2928783. [DOI] [PubMed] [Google Scholar]
  60. Wisniewski T., Ghiso J., Frangione B. Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem Biophys Res Commun. 1991 Sep 30;179(3):1247–1254. doi: 10.1016/0006-291x(91)91706-i. [DOI] [PubMed] [Google Scholar]
  61. Yankner B. A., Dawes L. R., Fisher S., Villa-Komaroff L., Oster-Granite M. L., Neve R. L. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science. 1989 Jul 28;245(4916):417–420. doi: 10.1126/science.2474201. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES